The healthcare industry revolves around patients. In today’s environment, patient-centered insights have become more critical than ever to help payers and pharmaceutical companies gain a deeper understanding of patient dynamics.
Using de-identified patient information, companies can identify patient populations that would benefit most from specific treatments and therapies and capture true market potential.
IMS LifeLink™ — our global program of patient-centered analytics and services provides the best-available view of patient dynamics in every key market, with data sourced from longitudinal prescriptions, medical claims and electronic medical records. To convert this data into relevant insights, we bring powerful, consistent methodologies that meet rigorous scientific standards, backed by hundreds of consultants who understand local healthcare systems.
- Learn more about our Patient-Centered Analytics.
- Click here to view LifeLink capabilities in the U.S.
Key LifeLink offerings in the U.S. market
IMS NPA Market Dynamics™
Patient-level insights integrated with IMS National Prescription Audit™ (NPA), incorporating source of business metrics — product switches, new therapy starts and refill patterns, with specific patient information such as diagnosis and compliance and persistence providing a view of the market dynamics impacting brand performance.
IMS Xponent Prescribing Dynamics™
At the prescriber level, combines the reliability of Xponent with insight into patient treatment decisions, allowing clients to more accurately segment and identify physicians, refine messages, adapt and change tactics and align sales compensation metrics that will impact the trend of a brand’s performance.
IMS PlanTrak Market Dynamics™
Integrates Xponent PlanTrak™ with patient-level data providing payer and plan level visibility within key performance indicators separating new, switch and repeat prescriptions to show how plans influence patient therapy choices. These new enhanced metrics further refine payer/plan segmentation, targeting and contracting, and pull through measurements.
Specialty Market Dynamics™
Integrates patient-level data from specialty pharmacy providers (SPPs), retail pharmacies, and standard mail service suppliers to help clients more accurately measure, monitor, and benchmark specialty market performance. At a national level, it provides compliance and persistence, product switching, source of business, and treatment regimens. For specialty products that compete in multiple disease categories, it also introduces a more complete view of drug use by indication based on diagnosis included directly on prescriptions from SPPs.